fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Breakthrough Discovery of New Drug to Treat Aggressive Brain Cancer

Discovery of New Drug to Treat Aggressive Brain Cancer
Neuroscientists at Sheba Medical Center have discovered a drug that could potentially cure terminally ill patients suffering from Glioblastoma (GBM), a particularly aggressive form of brain cancer.

Glioblastoma is widely regarded as the most common and life-threatening type of primary brain tumor. Research on treatments for GBM has been conducted extensively, yet the results have been limited and there is presently no cure for the disease.

Dr. Efrat Shavit-Stein and Professor Yoav Chapman have been developing this revolutionary treatment at the Joseph Sagol Neuroscience Center, at Sheba. They recently published the groundbreaking results in the leading journal Frontiers in Neurology. In their studies, they created a drug called SIXAC. During the first stage of testing, the effect of SIXAC on tumor cell cultures was analyzed and found to have reduced the rate of tumor growth, the cells’ ability to create colonies, and their capability to form extensions that penetrate the brain tissue.

In this highly progressive study at Sheba, the drug was injected directly into the high-grade malignant brain tumors of animals. In approximately 10 percent of the animals, the drug “significantly extended life and actually cured them of the disease,” as reported by researchers.

Currently, the research team at Sheba is continuing to develop SIXAC and its administration – striving to implement it “as soon as possible” for treating humans who suffer from deadly brain tumors. “The progress of research and development from now on will depend to a large extent on the financial investment in the project,” said Dr. Shavit-Stein.

Related
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More
Sheba Medical Center is working on enhancing patient safety with AI solutions.
News May 18.
Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.
News May 17.
Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More